Rhinitus/Sinusitis/Ocular Allergy News

Patients with cystic fibrosis had improved chronic rhinosinusitis outcomes after 1 year of elexacaftor/tezacaftor/ivacaftor therapy, according to results published in JAMA Otolaryngology-Head & Neck Surgery.

Patients with chronic rhinitis who had temperature-controlled radiofrequency neurolysis of their posterior nasal nerve experienced improved symptoms and quality of life, according to a study of 129 patients published in The Laryngoscope.

Sleep improved for patients with chronic rhinosinusitis with nasal polyps after a month of treatment with dupilumab, according to a study published in Annals of Allergy, Asthma & Immunology.

Yearly paranasal sinus MRI imaging allowed physicians to track chronic rhinosinusitis development in children with cystic fibrosis, according to results published in Annals of the American Thoracic Society.

Patients experienced a rapid reduction in allergic inflammation caused by an intradermal grass pollen challenge after one dose of a first-in-class peptide, according to a press release from Revolo Biotherapeutics.

Making a definitive diagnosis for a pediatric patient presenting with conjunctivitis can be difficult. Conjunctivitis in the pediatric patient can be mimicked by nasolacrimal duct (NLD) obstruction and caused by allergies, bacteria, and viruses. Because antimicrobial cultures take time and are not always accurate, the diagnosis and treatment of conjunctivitis are often based on the physician’s knowledge regarding the current literature on likely pathogens and clinical experience. Therefore, pediatricians must be aware of the clinical signs and symptoms that can provide a differential diagnosis of conjunctivitis, so that it can be properly treated.

Designed for over-the-counter use, the Bentrio nasal spray from Altamira Therapeutics was more effective in treating nasal symptoms in seasonal allergic rhinitis than saline solution, according to a press release from the company.

The Allergy-Immunology Joint Task Force on Practice Parameters has issued guidelines for the medical management of chronic rhinosinusitis with nasal polyps, according to a review published in Annals of Allergy, Asthma & Immunology.

An FDA panel voted unanimously against the efficacy of oral phenylephrine, an ingredient in many nasal decongestants sold over the counter to treat colds and allergy symptoms.

Infants with immature gut microbiota faced greater risks for developing atopic dermatitis, asthma, food allergy and allergic rhinitis by age 5 years, according to a study published in Nature Communications.